Anwita Biosciences, Inc. is a clinical stage biopharmaceutical company headquartered in the San Francisco Bay Area. We are advancing our product pipeline of improved cytokines (Exenokines, Mableukins etc) and tumor-targeting antibody drug conjugates. Our lead product, Exenokine-21, has been accepted by China NMPA and the US FDA to initiate clinical studies.
Our mission is to deliver transformative treatment options to improve the lives of patients with cancer and autoimmune diseases. We specialize in the discovery and development of optimized immunotherapeutics, leveraging our core expertise in cancer immunotherapy, bioinformatics, and target-based protein evolution.
Company Details
- Employees
- 9
- Address
- 300 Industrial Rd, San Carlos,california 94070,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://anwitabio.com/
- Keywords
- in cancer immunotherapy.
- HQ
- San Carlos, California
Anwita Biosciences Inc Questions
Anwita Biosciences Inc's website is https://anwitabio.com/
Anwita Biosciences Inc's LinkedIn profile is https://www.linkedin.com/company/anwitabio
Anwita Biosciences Inc has
9 employees.
View email and phone details for 9
employees at Anwita Biosciences Inc.
Anwita Biosciences Inc's industry is
Biotechnology Research
Anwita Biosciences Inc's top competitors are
Slingshot Biosciences,
Okava,
Enable Biosciences,
Peak Bio Inc.,
Altay Therapeutics,
Aridis Pharmaceuticals,
Bluelight Therapeutics, Inc.,
Teon Therapeutics Inc.,
Apstem Therapeutics,
Quadriga Biosciences, Inc..
Anwita Biosciences Inc's categories are Biotechnology Research
